Laurel M. Lee Stock Trades

Every disclosed transaction tied to Representative Laurel M. Lee's household with a 2026 transaction date has been a sale. Six transactions are dated this year, all sales, a sharp reversal from 2024, when seven of twelve disclosed transactions were purchases. Across the full disclosure record, which runs from May 2023 through July 2026, the household has 23 disclosed transactions: 9 purchases, 13 sales, and one exchange. Twenty-two of those 23 are attributed to a spouse rather than to Rep. Lee personally, and the pattern of activity, concentrated in large-cap technology and health care names with recurring activity in a small clinical-stage biotech, is worth walking through in detail.

The single exception to spousal attribution is also the transaction with the largest disclosed amount range on record. On May 24, 2023, a purchase of between $500,001 and $1,000,000 in the "Goldman Trust Fund, (LLC)" was disclosed under Rep. Lee's own name rather than her spouse's. The record supplies no ticker, sector, or company description for that entry. Every other transaction in the record, all 22 of them, carries a spouse attribution and should be read as reflecting activity attributed to a spouse, not as Rep. Lee's personal trades.

A shift from buying to selling

The year-by-year pattern is the clearest signal in the data. In 2023, three transactions are dated, one purchase and two sales. In 2024, activity jumped to twelve transactions, and purchases dominated: seven purchases against four sales and one exchange. That was the household's most active buying year by a wide margin. In 2025, activity slowed to two transactions, a purchase and a sale, evenly split. Then in 2026, the pattern flipped entirely: six transactions, all sales, with no purchases. Nokia Corporation ADR securities (NOK) accounted for four of those 2026 sales, dated May 11, June 2, and twice on July 6. The May 11 and June 2 stock transactions were marked as partial sales, while the two July 6 entries were option sales. A Bank of America (BAC) partial stock sale and a GE Aerospace (GE) option sale round out the 2026 activity; both transactions are dated in June, and all six 2026 transactions were disclosed on July 19.

Apple Inc. (AAPL), TuHURA Biosciences (HURA), and Nokia are tied as the most frequently disclosed securities overall, with four transactions each. Apple's transactions ran from July through October 2024: a purchase and a sale on the same day, July 5, followed by another purchase on July 31 and a further purchase on October 7. TuHURA, a clinical-stage immuno-oncology company, also appears four times, with three purchases and one exchange transaction between May 2024 and July 2025. Its most recent transaction was a purchase in the $50,001 to $100,000 range. That repeated activity involving a single small clinical-stage biotech stands out against the rest of the household's disclosures, which otherwise run largely through established companies. Nokia also appears four times, but all four transactions are sales, making it the only one of the three top-frequency securities with no purchase activity in the record.

By sector, Information Technology leads with eight disclosed transactions, followed by Health Care with six. Communication Services, Consumer Discretionary, Financials, and Industrials each show two transactions, and one transaction carries no assigned sector. The Health Care activity spans both TuHURA's clinical-stage biotech work and large pharmaceutical names: a Pfizer (PFE) purchase in October 2024 and a Novo Nordisk (NVO) partial sale in May 2025. The Financials transactions are a JPMorgan Chase (JPM) purchase in September 2024 and a Bank of America partial sale in June 2026. Alibaba Group Holding (BABA) appears in two disclosed transaction rows, both tied to a December 29, 2023 transaction date, and Warner Bros. Discovery (WBD) appears in two sale rows as well, both dated November 29, 2024. GE Vernova (GEV), an energy company operating across power, wind, and electrification, was sold in November 2024, while GE Aerospace, which designs and produces commercial and defense aircraft engines and related systems, was sold separately in June 2026.

On Quantellect's scoring system, Rep. Lee carries a Quantellect Score of 57, placing her in the "solid" tier as of August 21, 2026. Coverage is flagged as limited, and she ranks 34th in a 76-member scored cohort. For context on how unusual disclosed trading activity is at all, the population snapshot measured on August 22, 2026 lists 537 sitting members of Congress, 276 of whom have disclosed no trades, including 237 of the House's 437 sitting members. Rep. Lee's household, with 23 disclosed transactions dating back to 2023, falls outside that non-trading majority.

Taken together, the record shows a household that reported purchases throughout 2024 across technology, health care, and financials, then spent the first seven months of 2026 reporting sales involving Nokia, Bank of America, and GE Aerospace without a single purchase dated that year. The companies involved range from Apple's consumer hardware and services business to Nokia's network infrastructure equipment, JPMorgan's and Bank of America's diversified banking operations, Pfizer's and Novo Nordisk's pharmaceutical businesses, and TuHURA's clinical-stage cancer immunotherapy pipeline. It is a mix spanning some of the market's largest companies alongside one clinical-stage developer of cancer-treatment candidates.

Disclosure and methodology notes

This profile is built from official congressional financial disclosure filings and reflects transaction-level data only. Twenty-two of the 23 disclosed transactions are attributed to a spouse under House disclosure rules and should not be read as Rep. Lee's personal trading decisions. Dollar amounts reflect disclosed ranges, not exact transaction values. The year-by-year discussion uses transaction dates, which are distinct from filing dates. Periodic transaction reports are generally filed after the underlying transaction, consistent with reporting requirements under the Stop Trading on Congressional Knowledge Act of 2012. See the House Committee on Ethics financial disclosure instruction guide for filing methodology and the most recent periodic transaction report for the six transactions disclosed on July 19, 2026.